Evidence map›Paper›PMID 32616070›Full record

ArticleBMC research notes2020

Analysis of medico-social factors for return to work among patients presenting with haematological malignancy (adamantine): results of a 'pilot study'.

Bénédicte Clin, Natacha Heutte, Mathilde Boulanger, Xavier Troussard, Edouard Cornet, Ghandi Laurent Damaj, Véronique Bouvier, Anne-Valérie Guizard, Guy Launoy, Idlir Licaj

Abstract read
In one paragraph

Article in BMC research notes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bénédicte ClinINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France. benedicte.clin14@orange.fr.ORCID http://orcid.org/0000-0001-9138-5265
Natacha HeutteCETAPS EA3832, Université de Rouen, Mont-Saint-Aignan, France.
Mathilde BoulangerINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.
Xavier TroussardService d'Hématologie Clinique, CHU de Caen, Caen, France.
Edouard CornetRegistre des Hémopathies Malignes de Basse-Normandie, Caen, France.
Ghandi Laurent DamajService d'Hématologie Clinique, CHU de Caen, Caen, France.
Véronique BouvierINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.
Anne-Valérie GuizardINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.
Guy LaunoyINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.
Idlir LicajINSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to describe return to work determinants in patients with haematological malignancy.

resultsThis medico-social pilot study included patients with haematological malignancy in the département of Calvados, aged 18 to 55 years, diagnosed between 1st January and 31st December 2010 and alive at 1st January 2015. Patients were identified via consultation of the Lower Normandy haematological malignancy Registry. They completed a specially developed self-questionnaire, in addition to validated questionnaires for anxiety-depression, quality of life and fatigue. Of the patients contacted, 50% accepted to participate. The mean age at diagnosis was 49.8 years, and the majority of patients (79.2%) was professionally active at the time of diagnosis. Only 64.9% of subjects had stopped work due to illness. The psychological impact (demonstrated anxiety) was significantly greater in men (p = 0.01). The majority of subjects returned to work after treatment (80.7%) and among them, the mean duration of absence from work was 16.1 months. Only 52.6% of subjects had informed their occupational physician and 56.7% had benefited from a pre-return visit. The satisfactory response rate obtained is promising for the extension of the present project as a prospective multicentric study.

Indexed as

Hematologic NeoplasmsReturn to WorkAdolescentAdultAnxietyDepressionFatigueFemaleHumansMaleMiddle AgedPilot ProjectsQuality of LifeSocial FactorsYoung AdultCancerHaematological malignancyOccupational healthOccupational reintegrationReturn to workSocial inequalities

Identifiers

PMID32616070
PMCPMC7331231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.